Berodual Adverse Reactions

Many of the listed undesirable effects can be assigned to the anticholinergic and β-adrenergic properties of Berodual. As with all inhalation therapy, Berodual may show symptoms of local irritation. Adverse drug reactions were identified from data obtained in clinical trials and pharmacovigilance during post approval use of the drug.
The most frequent side effects reported in clinical trials were cough, dry mouth, headache, tremor, pharyngitis, nausea, dizziness, dysphonia, tachycardia, palpitations, vomiting, blood pressure systolic increased and nervousness, hypersensitivity, anaphylactic reactions, hypokalemia, agitation, mental disorder, glaucoma, increased intraocular pressure, accommodation disorder, mydriasis, blurred vision, eye pain, corneal oedema, conjunctival hyperaemia, halo vision, increased heart rate, palpitations, arrhythmia, atrial fibrillation, supraventricular tachycardia, myocardial ischaemia, cough, pharyngitis, dysphonia, bronchospasm, throat irritation, pharyngeal oedema, laryngospasm, bronchospasm paradoxical, dry throat, stomatitis, glossitis, gastrointestinal motility disorder, diarrhoea, constipation, mouth oedema, urticaria, rash, pruritus, angioedema, hyperhidrosis, muscular weakness, muscle spasms, myalgia, urinary retention, systolic increased blood pressure, diastolic decreased blood pressure.